New series of studies suggests that costs attributable to EDCs are over €150 billion per year in Europe
World Circular Economy Forum Online Event
US FDA updates to food contact inventory since August 2022
US Food and Drug Administration (FDA) adds 26 new entries to its Inventory of Effective Food Contact Substance Notifications (FCNs) since August 2022
Oligomers in biodegradable food packaging
Study of non-volatile components of biodegradable polyester and polylactic acid blend identifies 37 different compounds including plasticizers and oligomers, some seen only in migration experiments
Glosario
Listado alfabético de términos empleados en los temas de salud relacionados con los envases alimentarios.
U.S. consumers confused about compostable and biodegradable food packaging labels
Half of surveyed people have difficulty with the difference between compostable and biodegradable; 50% of participants fail to dispose of packaging correctly; report suggests better standardization and consumer education needed
German BfR comments on the Chemicals Strategy for Sustainability
The German Federal Institute for Risk Assessment (BfR) comments on the EU’s Chemicals Strategy for Sustainability (CSS); criticizes the alleged exclusion of scientific risk assessment experts in the development and implementation of the CSS; comments supported by others with demonstrated ties to chemical industry.
US FDA adds 15 substances to food contact inventory
US Food and Drug Administration (FDA) adds 15 new entries to its Inventory of Effective Food Contact Substance Notifications (FCNs) since October 2021; FDA proposes update to procedure to determine when FCNs are no longer effective; update open for comment until April 11, 2022
US FDA updates to food contact inventory since April
US Food and Drug Administration (FDA) adds 18 new entries to its Inventory of Effective Food Contact Substance Notifications (FCNs) since April 2022
ECHA committees reach consensus on PFHxS but not on resorcinol
Committee agrees to support Norway’s restriction proposal on manufacture and placing on the market of perfluorohexane sulfonic acid (PFHxS), its salts, and related substances; cannot reach consensus to identify resorcinol as substance of very high concern (SVHC), agree that it is endocrine disrupting under World Health Organization (WHO) definition